Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings

Pediatr Pulmonol. 2021 Jun;56(6):1374-1377. doi: 10.1002/ppul.25280. Epub 2021 Feb 1.

Abstract

Weather and the susceptibility of children to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is still a debated question and currently a hot topic, particularly in view of important decisions regarding opening schools. Therefore, we performed this prospective analysis of anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies in children with known household exposure to SARS-CoV-2 and compared their IgG status with the other adults exposed to the index case in the same household. A total of 30 families with a documented COVID-19 index case were included. A total of 44 out of 80 household contacts (55%) of index patients had anti SARS-CoV-2 IgG antibodies. In particular, 16/27 (59,3%) adult partners had IgG antibodies compared with 28/53 (52,3%) of pediatric contacts (p > .05). Among the pediatric population, children ≥5 years of age had a similar probability of having SARS-CoV-2 IgG antibodies (21/39, 53.8%) compared to those less than 5 years old (7/14, 50%) (p > .05). Adult partners and children also had a similar probability of having SARS-CoV-2 IgG antibodies. Interestingly, 10/28 (35.7%) of children and 5/27 (18.5%) of adults with SARS-CoV-2 IgG antibodies were previously diagnosed as COVID-19 cases. Our study shows evidence of a high rate of IgG antibodies in children exposed to SARS-CoV-2. This report has public health implications, highlighting the need to establish appropriate guidelines for school openings and other social activities related to childhood.

Keywords: COVID-19; SARS-CoV-2; children; household; seroprevalence.

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • COVID-19 / blood*
  • COVID-19 / immunology
  • COVID-19 / virology
  • Child
  • Child, Preschool
  • Environmental Exposure
  • Humans
  • Immunoglobulin G / blood*
  • Infant
  • Infant, Newborn
  • Middle Aged
  • SARS-CoV-2*
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral
  • Immunoglobulin G